Trevena
TRVN
#10620
Rank
C$0.01 M
Marketcap
C$0.01497
Share price
0.00%
Change (1 day)
-99.39%
Change (1 year)

Earnings for Trevena (TRVN)

Earnings in 2024 (TTM): -C$41.69 Million

According to Trevena's latest financial reports the company's current earnings are C$0.54 Million. In 2023 the company made an earning of -C$49.46 Million, an increase over its 2022 earnings that were of -C$71.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevena from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$41.69 Million-15.71%
2023 -C$49.46 Million-30.69%
2022 -C$71.36 Million1.38%
2021 -C$70.39 Million78.04%
2020 -C$39.54 Million21.3%
2019 -C$32.59 Million-13.91%
2018 -C$37.86 Million-59.75%
2017 -C$94.05 Million-31.77%
2016 -C$0.14 Billion101.73%
2015 -C$68.33 Million1.14%
2014 -C$67.57 Million114.83%
2013 -C$31.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
C$11.22 B-26,645.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.43 B-74,449.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-C$0.11 Billion 155.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.03 Billion 2,321.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-C$14.01 Million-66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-C$85.48 Million 102.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-C$0.86 Billion 1,918.69%๐Ÿ‡บ๐Ÿ‡ธ USA